1,294
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Interface Between Psychotropic Medications, Neurobiology, and Mental Illnesses

Pages 255-272 | Received 02 May 2014, Accepted 02 May 2014, Published online: 08 Aug 2014

REFERENCES

  • American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author.
  • Anda, R. F., Brown, D. W., Felitti, V. J., Bremner, J. D., Dube, S. R., & Giles, W. H. (2007). Adverse childhood experiences and prescribed psychotropic medications in adults. American Journal of Preventive Medicine, 32(5), 389–394.
  • Anda, R. F., Felitti, V. J., Walker, J., Whitfield, C. L., Bremner, J. D., Perry, B. D., … Giles, W. H. (2006). The enduring effects of abuse and related adverse experiences in childhood: A convergence of evidence from neurobiology and epidemiology. European Archives of Psychiatry and Clinical Neurosciences, 56(3), 174–186.
  • Anda, R. F., Whitfield, C. L., Felitti, V. J., Chapman, D., Edwards, V. J., Dube, S. R., & Williamson, D. F. (2002). Adverse childhood experiences, alcoholic parents, and later risk of alcoholism and depression. Psychiatric Services, 53(8), 1001–1009.
  • Andreasen, N. C. (2001). Brave new brain: Conquering mental illness in the era of the genome. New York, NY: Oxford University Press.
  • Bayliss, P. J. (2006). The neurobiology of affective interventions: A cross theoretical mode. Clinical Social Work Journal, 34(1), 61–81.
  • Bell, V. (2013, October). Changing brains: Why neuroscience is ending the Prozac era. Brain in the News, 1–2.
  • Belluck, P., & Carey, B. (2013, May 6). Psychiatry’s guide is out of touch with science, experts say. The New York Times. Retrieved from http://www.nytimes.com/2013/05/07/health/psychiatrys-new-guide-falls-short-experts-say.html?_r=0
  • Bentley, K. J. (2010). The meaning of psychiatric medication in a residential program for adults with serious mental illness. Qualitative Social Work, 9(4), 479–499.
  • Bentley, K. J., & Walsh, J. (2014). The social worker and psychotropic medication. Belmont, CA: Brooks/Cole.
  • Bentley, K. J., Walsh, J., & Farmer, R. L. (2005). Roles and activities of social workers with psychiatric medication: Results of a national survey. Social Work, 50, 295–303.
  • Bradley, S. J. (2000). Affect regulation and the development of psychopathology. New York, NY: Guilford.
  • Burroughs, V. J., Maxey, R. W., & Levy, R. A. (2002). Racial and ethnic differences in response to medicines: Towards individualized pharmaceutical treatment. Journal of the National Medical Association, 94(10, Suppl.), 1–26.
  • Butler, S., & Strupp, H. (1986). Specific and nonspecific factors in psychotherapy: A problematic paradigm for psychotherapy research. Psychotherapy, 23(1), 30–40.
  • Caley, C. F. (2011). Interpreting and applying CYP450 genomic test results to psychotropic medications. Journal of Pharmacy Practice, 24(5), 439–446.
  • Chapman, D. P., Whitfield, C. L., Felitti, V. J., Dube, S. R., Edwards, V. J., & Anda, R. F. (2004). Adverse childhood experiences and the risk of depressive disorders in adulthood. Journal of Affective Disorders, 82(2), 217–225.
  • Chen, C. H., Chen, C. U., & Lin, K. M. (2008). Ethnopsychopharmacology. International Review of Psychiatry, 20(5), 452–459.
  • Cozolino, L. J. (2002). The neuroscience of psychotherapy: Building and rebuilding the human brain. New York, NY: W.W. Norton.
  • Cozolino, L. J. (2006). The neuroscience of human relationships: Attachment and the developing social brain. New York, NY: W.W. Norton.
  • Daly, A. K., Brockmoller, J., Broly, F., Eichelbaum, M., Evans, W. E., Gonzalez, F. J., . . . Zanger, U. M. (1996). Nomenclature for human CYP2D6 alleles. Pharmacogenetics, 6, 193–201.
  • Dozier, M., Stovall, K. C., & Albus, K. (1999). Attachment and psychopathology in adulthood. In J. Cassidy & P. Shaver (Eds.), The handbook of attachment theory (pp. 648–673). New York, NY: Guilford Press.
  • Dube, S. R., Anda, R. F., Felitti, V. J., Edwards, V. J., & Croft, J. B. (2002). Adverse childhood experiences and personal alcohol abuse as an adult. Addictive Behavior, 27(5), 713–725.
  • Eisenberg, L. (1995). The social construction of the human brain. American Journal of Psychiatry, 152(11), 1563–1575.
  • Farmer, R. L. (2009). Neuroscience and social work practice: The missing link. Thousand Oaks, CA: Sage.
  • Floersch, J., Townsend, L., Longhofer, J., Munson, M., Winbush, V., Kranke, D., . . . Findling, R. L. (2009). Adolescent experience of psychotropic treatment. Transcultural Psychiatry, 46(1), 157–179.
  • Fonagy, P., Leigh, T., Steele, M., Steele, H., Kennedy, R., Mattoon, G., . . . Gerber, A. (1996). The relation of attachment status, psychiatric classification and response to psychotherapy. Journal of Consulting, and Clinical Psychology, 64(1), 22–31.
  • Fonagy, P., & Target, M. (2005). Bridging the transmission gap: An end to an important mystery of attachment research? Attachment and Human Development, 7(3), 333–343.
  • Friedman, R. A. (2013). Opinion: A dry pipeline for psychiatric drugs. Brain in the News, 20(7), 6–7.
  • Gergely, G., Fonagy, P., & Target, M. (2000). Attachment and borderline personality disorder: A theory and some evidence. Psychiatric Clinics of North America, 23(1), 103–123.
  • Grafton, S. T., Arbib, M. A., Fadiga, L., & Rizzolatti, G. (1996). Localization of grasp representation in humans by PET: 2. Observation compared with imagination. Experimental Brain Research, 112, 103–111.
  • Horvath, A., & Symonds, D. (1991). Relation between working alliance and outcome in psychotherapy: A meta-analysis. Journal of Counseling Psychology, 38(2), 139–149.
  • Hunter, R., Kennedy, E., Song, F., Gadon, L., & Irving, C. (2003). Risperidone versus typical antipsychotic medication for schizophrenia. Cochrane Database of Systematic Reviews, (2), CD000440. doi:10.1002/14651858.CD000440
  • Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., . . . Wang, P. (2010). Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. American Journal of Psychiatry, 167, 748–751.
  • Komossa, K., Rummel-Kluge, C., Hunger, H., Schwarz, H., Bhoopathi, P. S., Kissling, W., & Leucht, S. (2009, October 7). Ziprasidone versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews, (4), CD006627. doi:10.1002/14651858.CO006627.pub2
  • Komossa, K., Rummel-Kluge, C., Schwarz, S., Schmid, F., Hunger, H., Kissling, W., & Leucht, S. (2011, January 19). Risperidone versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews, (1), CD006626. doi:10.1002/14651858.CD006626.pub.2
  • Larkin, H., Felitti, V. J., & Anda, R. F. (2014). Social work and adverse childhood experiences research: Implications for practice and health policy. Social Work Public Health, 29(1), 1–16.
  • Lawson, W. B. (2000). Issues in pharmacotherapy for African Americans. In P. Ruiz (Ed.), Ethnicity and psychopharmacology (pp. 37–47). Washington, DC: American Psychiatric Press.
  • Lin, K. M., Smith, M. W., & Ortiz, V. (2001). Culture and psychopharmacology. Psychiatric Clinics of North America, 24(3), 523–538.
  • Lipton, B. (2005). The biology of belief. Santa Rosa, CA: Elite Books.
  • Luo, H. R., Poland, R. E., Lin, K. M., & Wan, Y. J. (2006). Genetic polymorphism of Cytochrome P450 2C19 in Mexican Americans: A cross-ethnic comparative study. Clinical Pharmacology Therapeutics, 80(1), 33–40.
  • Main, M. (1996). Introduction to the special section on attachment and psychopathology: Overview of the field of attachment. Journal of Consulting and Clinical Psychology, 64(2), 237–243.
  • Malik, M., Lake, J., Lawson, W. B., & Joshi, S. V. (2010). Culturally adapted pharmacotherapy and the integrative formulation. Child and Adolescent Psychiatric Clinics of North America, 19(4), 791–814.
  • Mendoza, R., Wan, Y. J., Poland, R. E., Smith, M., Zheng, Y., & Berman, N. (2001). CYP2D6 polymorphism in a Mexican American population. Clinical Pharmacology and Therapeutics, 70(6), 552–560.
  • National Institute of Mental Health. (2013). Research domain criteria (RDoC). Retrieved from http://www.nimh.nih.gov/research-priorities/rdoc/index.shtml
  • Pena, S. D. J. (2011). The fallacy of racial pharmacogenomics. Brazilian Journal of Medical and Biological Research, 44(4), 268–275.
  • Piscitelli, S. C., Burstein, A. H., Chaitt, D., Alfaro, R. M., & Falloon, J. (2000). Indinavir concentrations and St. John’s wort. Lancet, 355, 547–548.
  • Restak, R. (2003). The new brain. Emmaus, PA: Rodale.
  • Rizzolatti, G., & Craighero, L. (2004). The mirror neuron system. Annual Review of Neuroscience, 27, 169–192.
  • Sarris, J., Panossian, A., Schweitzer, I., Stough, C., & Scholey, A. (2011). Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. European Neuropsychopharmacology, 21(12), 841–860.
  • Schore, A. N. (2003). Affect dysregulation and disorders of the self. New York, NY: W.W. Norton.
  • Schore, J. R., & Schore, A. N. (2008). Modern attachment theory. Clinical Social Work Journal, 36(1), 9–20.
  • Siegel, D. J. (2006). An interpersonal neurobiology approach to psychotherapy. Psychiatric Annals, 36(4), 248–256.
  • Smith, M. W. (2006). Ethnopsychopharmacology. In R. F. Lim (Ed.), Clinical manual of cultural psychiatry (pp. 207–235). Washington, DC: American Psychiatric Publishing.
  • Taupin, P. (2005). Adult neurogenesis in the mammalian central nervous system: Functionality and potential clinical interest. Medical Science Monitor, 11(7), RA247–RA252.
  • Wing, Y. K., Chan, E., Chan, K., Lee, S., & Shek, C. C. (1997). Lithium pharmacokinetics in Chinese manic-depressive patients. Journal of Clinical Psychopharmacology, 17(3), 179–184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.